DOTA-NOC-PET/CT aids neuroendocrine tumor treatment

March 9, 2012

PET/CT scans with the radiotracer gallium-68 (Ga-68) DOTA-NOC are "highly sensitive and specific" for detecting gastroenteropancreatic neuroendocrine tumors, outperforming conventional imaging such as CT, ultrasound, and MRI, according to a study published in the November issue of the American Journal of Roentgenology.